An economic analysis of Radiation Therapy Oncology Group 94-10: cost-efficacy of concurrent vs. sequential chemoradiotherapy

Background Cost can be a major issue in therapeutic decision-making and in particular for patients with locally advanced non-small cell lung cancer (LA-NSCLC).